Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence

Published on 16 Apr 2023 on Medical Xpress

The combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of...

Read the rest of the article

Start tracking your investments with Statfolio

Investing.com 16 Jun 2023

Coherus BioSciences Inc (NASDAQ: CHRS) has agreed to acquire Surface Oncology Inc (NASDAQ: SURF),...

Benzinga via Yahoo Finance 16 Jun 2023

Surface Oncology Inc. stock is up 49% in premarket trades on Friday after the cancer drug company...

Market Watch 16 Jun 2023

ARK Invest’s 13F portfolio value increased from $11.54B to $14.55B this quarter. Click here for a...

Seeking Alpha 19 Apr 2023

The combination of an experimental mRNA vaccine with an immunotherapy reduced the likelihood of...

Medical Xpress 16 Apr 2023

Atreca, Inc. (NASDAQ:BCEL) Q4 2022 Earnings Call Transcript March 29, 2023 Operator: Thank you fo...

Insider Monkey via Yahoo Finance 1 Apr 2023

The PoNS device is approved as...Fore Biotherapeutics The Philadelphia-based precision stage ...

American City Business Journals 24 Mar 2023

In France, the ninth day of demonstrations against a pension reform that would raise the minimum ...

Hardwood Paroxysm 23 Mar 2023

Walgreens Boots Alliance, Inc. WBA is slated to release second-quarter fiscal 2023 results on Mar...

Zacks via Yahoo Finance 20 Mar 2023

Chimerix, Inc. (NASDAQ:CMRX) Q4 2022 Earnings Call Transcript March 2, 2023 Operator: Good mornin...

Insider Monkey via Yahoo Finance 6 Mar 2023